Moderna MRNA Breaks to a New 52-Week High at $242.08
As seen on the 24/7 Wall St. homepage on October 20, 2026.
Moderna just set a fresh 52-week high at $242.08, 2.36% above the peak it reached on October 15. A year ago the stock traded near $27.
Continue ReadingShow less
Moderna hit a new 52-week high of $242.08 on October 20, clearing the prior peak set just five days earlier. With no overhead resistance left, there is no obvious technical ceiling on the stock.
A year ago the stock traded near $27, so holders have seen it multiply nearly nine times in twelve months. Investors who missed that move have a shrinking window to justify chasing it.
The steepest leg came in recent weeks, with the stock climbing from the $63 range to $174 before pushing through the $200s. A move that fast points to a catalyst rather than slow accumulation.
A fresh 52-week high with the prior peak only days old signals sustained buying pressure. Watch whether the stock holds above that October 15 peak on any pullback, since it is now the first meaningful support.
Sources
Mentioned: MRNA